Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scheifele

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Vaccine|June 19, 2010
A nationwide survey of past hepatitis A infections among Canadian adultsDavid W Scheifele, Gaston De Serres, Vladimir Gilca, et al.
Vaccine|December 31, 2013
Approved but non-funded vaccines: accessing individual protectionDavid W Scheifele, Brian J Ward, Scott A Halperin, et al.
The Pediatric Infectious Disease Journal|May 29, 2007
Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005Gordean Bjornson, David W Scheifele, Julie Bettinger, et al.
Clinical Trials (London, England)|September 9, 2011
Strategies for successful rapid trials of influenza vaccineDavid W Scheifele, Kim Marty, Carol LaJeunesse, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2010
Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selectionNicole Le Saux, Julie A Bettinger, Susan Wootton, et al.
The Pediatric Infectious Disease Journal|May 14, 2009
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United StatesDavid P Greenberg, Martha Doemland, Julie A Bettinger, et al.
Vaccine|June 2, 2012
Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trialDavid W Scheifele, Brian J Ward, Marc Dionne, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 5, 2013
Cost effectiveness of infant vaccination for rotavirus in CanadaDoug Coyle, Kathryn Coyle, Julie A Bettinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2015
Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort studyManish Sadarangani, David W Scheifele, Scott A Halperin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2014
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012Manish Sadarangani, David W Scheifele, Scott A Halperin, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Vaccine|June 19, 2010
A nationwide survey of past hepatitis A infections among Canadian adultsDavid W Scheifele, Gaston De Serres, Vladimir Gilca, et al.
Vaccine|December 31, 2013
Approved but non-funded vaccines: accessing individual protectionDavid W Scheifele, Brian J Ward, Scott A Halperin, et al.
The Pediatric Infectious Disease Journal|May 29, 2007
Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005Gordean Bjornson, David W Scheifele, Julie Bettinger, et al.
Clinical Trials (London, England)|September 9, 2011
Strategies for successful rapid trials of influenza vaccineDavid W Scheifele, Kim Marty, Carol LaJeunesse, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2010
Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selectionNicole Le Saux, Julie A Bettinger, Susan Wootton, et al.
The Pediatric Infectious Disease Journal|May 14, 2009
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United StatesDavid P Greenberg, Martha Doemland, Julie A Bettinger, et al.
Vaccine|June 2, 2012
Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: results of a randomized, controlled trialDavid W Scheifele, Brian J Ward, Marc Dionne, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 5, 2013
Cost effectiveness of infant vaccination for rotavirus in CanadaDoug Coyle, Kathryn Coyle, Julie A Bettinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2015
Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort studyManish Sadarangani, David W Scheifele, Scott A Halperin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2014
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012Manish Sadarangani, David W Scheifele, Scott A Halperin, et al.
Pageof 8